Missouri $1.5 Million Medical Malpractice Verdict
July 21, 2012
Earlier this month, a Missouri medical malpractice jury returned a verdict in favor of the plaintiff in a medical malpractice case that alleged that an 88-year-old woman who was a resident of a Missouri nursing home was left unattended and standing alone in her room after an aide helped her with [...]
Continue Reading
Massive New York Medicaid Drug Fraud Alleged
July 19, 2012
Federal prosecutors have charged 48 people in a massive Medicaid drug fraud scheme that cost taxpayers upwards of $500 million. The fraud allegedly involved Medicaid recipients who were prescribed expensive medications who sold their drugs to third-parties for cash. The third-parties then sold th[...]
Continue Reading
Dismissal Of Ohio Medical Malpractice Case Upheld
July 17, 2012
In an appeal of the dismissal of an Ohio medical malpractice case, the Court of Appeals of Ohio upheld the dismissal in its opinion filed on July 10, 2012. The trial court had dismissed the medical malpractice case because the medical malpractice plaintiff allegedly had failed to comply with an Oh[...]
Continue Reading
Today We Celebrate Our 500th Consecutive Daily Blog!
July 16, 2012
Today’s blog is the 500th consecutive daily blog that we have posted. We feel a great deal of pride and enormous satisfaction having reached this milestone. Looking back on our previous 499 consecutive daily blogs, we realize just how much ground we have covered: we have discussed medical m[...]
Continue Reading
West Virginia Medical Malpractice Claim For Hearing Loss
July 14, 2012
A medical malpractice plaintiff in West Virginia filed his medical malpractice claim against a physician and the physician’s medical practice on June 18, 2012, alleging that the physician failed to timely and properly diagnosis the man’s complaints of hearing loss. The medical malpra[...]
Continue Reading
Fosamax Claims
July 13, 2012
Fosamax (alendronate sodium) is a brand-name prescription drug manufactured by Merck that was first approved for use in the U.S. in 1995. Fosamax is in a class of medications called biphosphonates that increase bone density and prevent bone loss. It is used to prevent and treat osteoporosis in wome[...]
Continue Reading